Tourbillon Capital Partners LP Has Lowered Its Cognizant Technology Solutio (CTSH) Stake as Stock Value Rose; Glaxosmithkline Plc (GSK) Share Value Rose While Clearbridge Investments Trimmed Position

May 27, 2018 - By Winifred Garcia

GlaxoSmithKline plc (NYSE:GSK) Logo

Clearbridge Investments Llc decreased its stake in Glaxosmithkline Plc (GSK) by 49.39% based on its latest 2017Q4 regulatory filing with the SEC. Clearbridge Investments Llc sold 120,911 shares as the company’s stock rose 9.28% while stock markets declined. The institutional investor held 123,892 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $4.39M, down from 244,803 at the end of the previous reported quarter. Clearbridge Investments Llc who had been investing in Glaxosmithkline Plc for a number of months, seems to be less bullish one the $98.83B market cap company. The stock decreased 0.45% or $0.18 during the last trading session, reaching $39.85. About 1.88 million shares traded. GlaxoSmithKline plc (NYSE:GSK) has declined 10.07% since May 27, 2017 and is downtrending. It has underperformed by 21.62% the S&P500.

Jason Karp decreased its stake in Cognizant Technology Solutio (CTSH) by 6.92% based on its latest 2017Q4 regulatory filing with the SEC. Tourbillon Capital Partners Lp sold 69,197 shares as the company’s stock rose 11.69% while stock markets declined. The hedge fund run by Jason Karp held 930,803 shares of the edp services company at the end of 2017Q4, valued at $66.11M, down from 1.00 million at the end of the previous reported quarter. Tourbillon Capital Partners Lp who had been investing in Cognizant Technology Solutio for a number of months, seems to be less bullish one the $44.40B market cap company. The stock decreased 0.20% or $0.15 during the last trading session, reaching $75.78. About 2.44 million shares traded. Cognizant Technology Solutions Corporation (NASDAQ:CTSH) has risen 36.40% since May 27, 2017 and is uptrending. It has outperformed by 24.85% the S&P500.

Analysts await GlaxoSmithKline plc (NYSE:GSK) to report earnings on July, 25. They expect $0.78 EPS, up 11.43% or $0.08 from last year’s $0.7 per share. GSK’s profit will be $1.93B for 12.77 P/E if the $0.78 EPS becomes a reality. After $0.68 actual EPS reported by GlaxoSmithKline plc for the previous quarter, Wall Street now forecasts 14.71% EPS growth.

Among 18 analysts covering GlaxoSmithKline (NYSE:GSK), 9 have Buy rating, 1 Sell and 8 Hold. Therefore 50% are positive. GlaxoSmithKline had 29 analyst reports since September 8, 2015 according to SRatingsIntel. The stock has “Buy” rating by Berenberg on Friday, May 26. The rating was upgraded by BNP Paribas on Wednesday, April 4 to “Buy”. BNP Paribas upgraded the shares of GSK in report on Tuesday, September 15 to “Neutral” rating. On Thursday, October 20 the stock rating was initiated by Investec with “Buy”. The firm has “Hold” rating by Bank of America given on Thursday, October 26. The rating was downgraded by BNP Paribas to “Underperform” on Wednesday, September 14. The rating was maintained by Argus Research on Friday, August 12 with “Buy”. The stock has “Buy” rating by Argus Research on Monday, December 7. The company was upgraded on Thursday, July 14 by Jefferies. The firm earned “Neutral” rating on Wednesday, July 5 by Citigroup.

Clearbridge Investments Llc, which manages about $108.23 billion US Long portfolio, upped its stake in Aspen Technology Inc (NASDAQ:AZPN) by 11,739 shares to 2.30M shares, valued at $152.13 million in 2017Q4, according to the filing. It also increased its holding in Alphabet Inc by 31,714 shares in the quarter, for a total of 679,128 shares, and has risen its stake in Canadian Pac Ry Ltd (NYSE:CP).

More important recent GlaxoSmithKline plc (NYSE:GSK) news were published by: Seekingalpha.com which released: “Xenon Pharma up 21% premarket on positive XEN1101 data” on May 15, 2018, also Streetinsider.com published article titled: “GlaxoSmithKline (GSK) with Pfizer (PFE) Reports ViiV Healthcare Granted EU Marketing Authorisation for Juluca …”, Streetinsider.com published: “GlaxoSmithKline (GSK) Indian Consumer Unit Receives Frenzy of Interest – Economic Times” on May 23, 2018. More interesting news about GlaxoSmithKline plc (NYSE:GSK) was released by: Seekingalpha.com and their article: “GlaxoSmithKline Q1 2018: Still Too Many Uncertainties” with publication date: April 29, 2018.

Tourbillon Capital Partners Lp, which manages about $1.12 billion and $2.70B US Long portfolio, upped its stake in Incyte Corp (NASDAQ:INCY) by 39,607 shares to 294,607 shares, valued at $27.90M in 2017Q4, according to the filing. It also increased its holding in Vantiv Inc (NYSE:VNTV) by 90,000 shares in the quarter, for a total of 1.81 million shares, and has risen its stake in Spectrum Brands Hldgs Inc (NYSE:SPB).

Investors sentiment increased to 1.19 in 2017 Q4. Its up 0.16, from 1.03 in 2017Q3. It improved, as 46 investors sold CTSH shares while 285 reduced holdings. 107 funds opened positions while 288 raised stakes. 491.94 million shares or 0.85% more from 487.81 million shares in 2017Q3 were reported. Geode Capital Mngmt Ltd Limited Liability Company holds 6.01 million shares or 0.14% of its portfolio. Vigilant Cap Mgmt Limited Co invested in 467 shares. 160 are held by Tortoise Mngmt Limited. Winslow Evans Crocker has 26,562 shares for 0.61% of their portfolio. Tower Bridge Advsrs holds 1.37% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH) or 179,363 shares. Meag Munich Ergo Kapitalanlagegesellschaft Mbh holds 65,393 shares or 0.18% of its portfolio. Rampart Invest Mngmt Limited Liability Company reported 0.22% of its portfolio in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Envestnet Asset Mngmt Incorporated reported 471,355 shares or 0.07% of all its holdings. Arkansas-based Ifrah Financial Serv Inc has invested 0.15% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Alyeska Gp Incorporated LP owns 0.02% invested in Cognizant Technology Solutions Corporation (NASDAQ:CTSH) for 28,088 shares. Boston Private Wealth Lc holds 27,313 shares or 0.07% of its portfolio. Fil Ltd reported 0.44% in Cognizant Technology Solutions Corporation (NASDAQ:CTSH). Moreover, Dupont Mngmt has 0.09% invested in Cognizant Technology Solutions Corporation (NASDAQ:CTSH) for 56,933 shares. Cohen Klingenstein Limited Liability Corporation reported 22,660 shares. Moreover, Badgley Phelps And Bell has 0.69% invested in Cognizant Technology Solutions Corporation (NASDAQ:CTSH).

Since December 7, 2017, it had 1 buying transaction, and 40 sales for $51.92 million activity. Mehta Rajeev sold $671,882 worth of stock. $136,950 worth of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) was sold by CHATTERJEE DEBASHIS. Shares for $942,113 were sold by McLoughlin Karen on Tuesday, January 16. $1.95M worth of stock was sold by RAMAKRISHNAN CHANDRASEKARAN on Monday, January 22. $798,094 worth of stock was sold by Kandiah Gajakarnan Vibushanan on Wednesday, February 14. The insider Frank Malcolm sold 1,091 shares worth $89,584.

Among 33 analysts covering Cognizant Technology Solutions Corp. (NASDAQ:CTSH), 26 have Buy rating, 1 Sell and 6 Hold. Therefore 79% are positive. Cognizant Technology Solutions Corp. had 92 analyst reports since August 6, 2015 according to SRatingsIntel. RBC Capital Markets maintained the stock with “Buy” rating in Wednesday, July 12 report. The stock has “Buy” rating by Robert W. Baird on Friday, September 8. As per Friday, July 28, the company rating was maintained by Cowen & Co. Needham maintained it with “Buy” rating and $100.0 target in Wednesday, February 7 report. The firm has “Buy” rating by RBC Capital Markets given on Thursday, August 3. On Wednesday, February 7 the stock rating was maintained by J.P. Morgan with “Buy”. The stock has “Underperform” rating by Bank of America on Tuesday, November 22. Zacks upgraded the shares of CTSH in report on Monday, August 10 to “Sell” rating. The firm has “Outperform” rating given on Thursday, November 2 by BMO Capital Markets. The stock of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) earned “Outperform” rating by BMO Capital Markets on Thursday, February 8.

Another recent and important Cognizant Technology Solutions Corporation (NASDAQ:CTSH) news was published by Prnewswire.com which published an article titled: “Cognizant to Present at the Bernstein 34th Annual Strategic Decisions Conference” on May 23, 2018.

Cognizant Technology Solutions Corporation (NASDAQ:CTSH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Winifred Garcia

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: